This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Acurx Pharmaceuticals, LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Casey McComas
Introduction
Casey McComas is a notable inventor based in Phoenixville, Pennsylvania. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target bacterial infections. His work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents
McComas holds a patent for "DNA polymerase IIIC inhibitors and use thereof." This invention relates to compounds that inhibit the DNA polymerase IIIC enzyme, which is crucial in the treatment of Gram-positive bacterial infections. The patent outlines methods for using these compounds and includes pharmaceutically acceptable compositions that can be utilized in medical treatments.
Career Highlights
Currently, Casey McComas is employed at Acurx Pharmaceuticals, LLC, where he continues to develop groundbreaking therapies. His work at Acurx focuses on creating effective treatments for bacterial infections, showcasing his dedication to improving patient outcomes through innovative research.
Collaborations
One of his notable coworkers is Li Huang Xing, who contributes her expertise to their shared projects. Together, they work towards advancing the company's mission of developing novel therapeutic solutions.
Conclusion
Casey McComas exemplifies the spirit of innovation in the biotechnology sector. His patent for DNA polymerase IIIC inhibitors highlights his commitment to addressing critical health challenges. Through his work at Acurx Pharmaceuticals, he continues to make strides in the fight against bacterial infections.